C6ORF162 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.66311409088848E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
3.12960768411585E-12 |
Normal-vs-Stage2 |
3.44999999679629E-08 |
Normal-vs-Stage3 |
1.62481139653892E-12 |
Normal-vs-Stage4 |
1.62481139653892E-12 |
Stage1-vs-Stage2 |
9.991800E-01 |
Stage1-vs-Stage3 |
1.954330E-04 |
Stage1-vs-Stage4 |
1.276500E-03 |
Stage2-vs-Stage3 |
4.916400E-02 |
Stage2-vs-Stage4 |
5.742200E-02 |
Stage3-vs-Stage4 |
9.757800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.64490643328463E-12 |
Normal-vs-AfricanAmerican |
7.92250043346598E-10 |
Normal-vs-Asian |
1.583180E-03 |
Caucasian-vs-AfricanAmerican |
9.112400E-02 |
Caucasian-vs-Asian |
8.141400E-01 |
AfricanAmerican-vs-Asian |
3.444800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
4.32986979603811E-14 |
Normal-vs-Female |
1.69686487083709E-12 |
Male-vs-Female |
9.217600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
5.89740001277761E-09 |
Normal-vs-Age(41-60Yrs) |
1.36002320516582E-13 |
Normal-vs-Age(61-80Yrs) |
4.57411886145564E-14 |
Normal-vs-Age(81-100Yrs) |
9.86729586927027E-11 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.657000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.591600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.482200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.344400E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.426200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.703800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
2.194500E-04 |
Normal-vs-Grade 2 |
1.5279999487916E-11 |
Normal-vs-Grade 3 |
1.62725388719309E-12 |
Normal-vs-Grade 4 |
1.62447832963153E-12 |
Grade 1-vs-Grade 2 |
2.714000E-01 |
Grade 1-vs-Grade 3 |
8.924600E-03 |
Grade 1-vs-Grade 4 |
5.89420000000063E-05 |
Grade 2-vs-Grade 3 |
1.158620E-03 |
Grade 2-vs-Grade 4 |
3.01300000504767E-08 |
Grade 3-vs-Grade 4 |
1.664790E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
4.02520017317443E-10 |
Normal-vs-ccB subtype |
1.11022302462516E-16 |
ccA subtype-vs-ccB subtype |
6.38529999985593E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.5976109324356E-13 |
Normal-vs-N1 |
1.62614366416847E-12 |
N0-vs-N1 |
3.63840000000559E-05 |
|
|